The image on the left is immunohistochemistry of paraffin-embedded Human prostate cancer tissue using CSB-PA698627(PLCL1 Antibody) at dilution 1/40, on the right is treated with synthetic peptide. (Original magnification: x200)
The image on the left is immunohistochemistry of paraffin-embedded Human prostate cancer tissue using CSB-PA698627(PLCL1 Antibody) at dilution 1/40, on the right is treated with synthetic peptide. (Original magnification: x200)
PLCL1 Antibody
CSB-PA698627
ApplicationsELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman
TargetPLCL1
Overview
- SupplierCusabio
- Product NamePLCL1 Antibody
- Delivery Days Customer20
- ApplicationsELISA, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- FormulationLiquid
- Gene ID5334
- Target namePLCL1
- Target descriptionphospholipase C like 1 (inactive)
- Target synonymsinactive phospholipase C-like protein 1; phospholipase C, epsilon; phospholipase C-deleted in lung carcinoma; phospholipase C-like 1; phospholipase C-related but catalytically inactive protein; PLCE; PLCL; PLC-L1; PLDL1; PPP1R127; PRIP; protein phosphatase 1, regulatory subunit 127
- HostRabbit
- IsotypeIgG
- Protein IDQ15111
- Protein NameInactive phospholipase C-like protein 1
- Scientific DescriptionPLC-L (for PLC-deleted in lung carcinoma) is a PLC family memeber, the expression of which is decreased in small cell lung carcinomas. PLC-L is normally expressed in a variety of fetal and adult organs including the lung. PLC-L is thought to be involved in inositol phospholipid-based intracellular signaling cascade and aberrant expression of PLC-L may contributes to the genesis or progression of human lung carcinoma.
- ReactivityHuman
- Storage Instruction-20°C or -80°C
- UNSPSC12352203